2,3-dinor-thromboxane b2 has been researched along with Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbate, M; Benigni, A; Bertani, T; Chiabrando, C; Furci, L; Gavinelli, M; Patino, O; Perico, N; Piccinelli, A; Remuzzi, G | 1 |
1 other study(ies) available for 2,3-dinor-thromboxane b2 and Kidney Diseases
| Article | Year |
|---|---|
Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity.
Topics: Animals; Blood Platelets; Cyclosporins; Endothelium, Vascular; Glomerular Filtration Rate; Kidney Diseases; Kidney Glomerulus; Kidney Tubules, Proximal; Macrophages; Male; Rats; Rats, Inbred Strains; Renal Circulation; Thromboxane B2 | 1988 |